Active Ingredient (In Each Softgel)
Docusate Sodium 250 mg
The following Structured Product Label (SPL) was submitted to the FDA by Pd-rx Pharmaceuticals, Inc. for the product Docusate Sodium (NDC 72789-166). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each softgel), purpose, uses, warnings do not use:, ask a doctor before use, stop use and ask a doctor, if pregnant or breast-feeding,, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Docusate Sodium 250 mg
Stool Softener
if you notice a sudden change in bowel habits that persists over a period of two weeks.
if you have rectal bleeding or you fail to have a bowel movement after use.
ask a healthcare professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (800) 222-1222.
Adults and Children over 12 years of age | Take orally 1 softgel preferably at bedtime for
|
Children under 12 years of age | Do not use this product for children under 12 years of age, unless directed by a doctor. |
FD&C Red #40, FD&C Yellow #6, Gelatin, Glycerin, Ink (Edible), Polyethylene Glycol, Propylene Glycol, Purified Water, Sorbitol.
Quwstions of Comments Call 1 (800) 682-9862
For identification purposes, each softgel will have an imprint that reads NV12.
NDC 72789-166-60 Bottles of 60 softgels.
* Please review the disclaimer below.